About Glenmark
Making an impact
Founded more than 40 years ago, Glenmark is a global company with a remarkable track record of achievement, improving patients’ lives with access to medicines.
Founded more than 40 years ago, Glenmark is a global company with a remarkable track record of achievement, improving patients’ lives with access to medicines.
In the United Kingdom we began operations in 2004 and we have emerged as a key generics organisation. Today we have a diverse business. As a global leader in generics, we are leveraging our industry expertise and success to fuel extensive research and develop innovative, branded products that will have a major impact on how people live. We are active in supplying medicines to the NHS including NHS Hospitals.
Glenmark has the stability, resources and talent to work on solving serious medical problems with breakthrough technology, all while doing the right thing for our patients, our people and our communities.
And we have momentum on our side, with a highly focused pipeline. Please see our Research & Development section for more information on our approach and innovative pipeline in the core therapeutic areas of oncology, dermatology and respiratory.
Powered by the energy, intellect and passion of our talented scientists, engineers, quality specialists and other skilled professionals, our work at Glenmark has purpose; together we accelerate research, solve complex analytical challenges, drive innovation and help improve patients’ lives. Each one of us contributes to our mission every day.
We have a unique combination of intellectual assets, commercial capabilities and strategic vision required to develop and market innovative branded drugs.
With a self-sustaining business model, we believe Glenmark is uniquely positioned to leverage our strong generics business and grow to realise the full potential of our own proprietary medicines.
Our scientific and commercial goals are grounded in the expertise of an elite team of industry veterans. We are determined to innovate: to question accepted wisdom, create new ideas, offer new approaches and never rest on our laurels. We are self-starters who reimagine creative solutions for our patients’ and doctors’ needs. We work passionately to retain the entrepreneurial spirit that created Glenmark more than 40 years ago.
Learn more about Glenmark:
Glenmark Pharmaceuticals Europe Ltd.
Building 2, Croxley Park, Watford WD18 8YA
Phone: +44 1923 202950
Customer Services/Orders
E-mail: Orders.UK@glenmarkpharma.com
Medical Information
Phone: 0800 458 0383
E-mail: medical_information@glenmarkpharma.com
WINLEVI® (clascoterone) 10 mg/g cream is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.2
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Glenmark Pharmaceuticals Europe Ltd medical_information@glenmarkpharma.com or call 0800 458 0383.
Depicted people are not actual patients.
